Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotrophic Keratopathy”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Not applicableNot Yet RecruitingNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Testing effectiveness (Phase 2)Study completedNCT04957758
What this trial is testing

Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy

Who this might be right for
Neurotrophic Keratopathy
Oyster Point Pharma, Inc. 113
Early research (Phase 1)Active Not RecruitingNCT06597422
What this trial is testing

STSP-0902 Ophthalmic Solution in Healthy Subjects

Who this might be right for
Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd 80
Not applicableUnknownNCT05940376
What this trial is testing

Topical Insulin in Neurotrophic Keratopathy After Diabetic Vitrectomy

Who this might be right for
Corneal UlcerNeurotrophic Corneal UlcerDiabetes Mellitus
Benha University 30
Large-scale testing (Phase 3)Study completedNCT01794312
What this trial is testing

Efficacy and Safety Assessment of T4020 Versus Vehicule in Patients With Chronic Neurotrophic Keratitis or Corneal Ulcer

Who this might be right for
KeratitisCorneal Ulcer
Laboratoires Thea 152
Testing effectiveness (Phase 2)Study completedNCT02227147
What this trial is testing

Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 48
Not applicableUnknownNCT05566717
What this trial is testing

An Investigator-Initiated Study to Assess the Association of Diabetic Retinopathy Severity Scale (DRSS) With Level of Decreased Corneal Sensitivity

Who this might be right for
Diabetic RetinopathyNeurotrophic Keratitis
Medical Center Ophthalmology Associates 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT06331910
What this trial is testing

Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers

Who this might be right for
Neurotrophic Keratopathy
Assiut University 14
Not applicableStudy completedNCT04820010
What this trial is testing

Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3

Who this might be right for
Corneal UlcerCorneal PerforationCorneal Epithelium Defect+1 more
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. 20
Large-scale testing (Phase 3)Ended earlyNCT02600429
What this trial is testing

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Who this might be right for
Neurotrophic Keratopathy
ReGenTree, LLC 18
Not applicableNot Yet RecruitingNCT07073729
What this trial is testing

Corneal Neurotization vs. Cenergermin for Neurotrophic Keratitis: A Pilot Study

Who this might be right for
Neurotrophic Keratitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 10
Testing effectiveness (Phase 2)Looking for participantsNCT06975748
What this trial is testing

A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Staidson (Beijing) Biopharmaceuticals Co., Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT03084861
What this trial is testing

A Clinical Trial to Asses Efficacy and Safety of Cord Blood Eye Drops in Neurotrophic Keratopathy

Who this might be right for
Neurotrophic Keratopathy
Banc de Sang i Teixits 9
Testing effectiveness (Phase 2)Study completedNCT01756456
What this trial is testing

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

Who this might be right for
Neurotrophic KeratitisKeratitisCorneal Ulcer
Dompé Farmaceutici S.p.A 174
Post-approval studies (Phase 4)Study completedNCT04485546
What this trial is testing

Study to Evaluate OXERVATE® in Patients With Stage 1 Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 37
Not applicableStudy completedNCT05552261
What this trial is testing

DEFENDO Long Term Follow-up Study in Stage 1 NK Patients

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 24
Testing effectiveness (Phase 2)Study completedNCT07120308
What this trial is testing

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Who this might be right for
Corneal Epithelial Defect
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 28
Testing effectiveness (Phase 2)Looking for participantsNCT06999733
What this trial is testing

A Study Assessing KB801 for the Treatment of Stage 2 or 3 Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
Krystal Biotech, Inc. 27
Large-scale testing (Phase 3)Looking for participantsNCT05555589
What this trial is testing

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

Who this might be right for
Neurotrophic Keratopathy
ReGenTree, LLC 70
Post-approval studies (Phase 4)Active Not RecruitingNCT06947850
What this trial is testing

DOMPE -MT Neurotrophic Keratitis

Who this might be right for
Dry EyeNeurotrophic Keratitis
Toyos Clinic 10
Load More Results